March 17, 2020 / 9:08 PM / 12 days ago

BRIEF-NGM Bio Reports Q4 Net Loss Per Share Of $0.24

March 17 (Reuters) - NGM Biopharmaceuticals Inc:

* NGM BIO REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* NGM BIOPHARMACEUTICALS - QTRLY NET LOSS PER SHARE $0.24

* NGM BIOPHARMACEUTICALS - QTRLY RELATED PARTY REVENUE FROM COLLABORATION WITH MERCK WAS $31.1 MILLION VERSUS $47.1 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below